More

    Europe Markets

    Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.)

    OverviewRiarify is a medicine used in adults to relieve the symptoms of moderate to severe chronic obstructive pulmonary disease (COPD). COPD is a...

    Inaqovi | European Medicines Agency (EMA)

    OverviewInaqovi is a cancer medicine used in adults to treat newly diagnosed acute myeloid leukaemia (AML), a type of cancer affecting the white...

    Entecavir Viatris (previously Entecavir Mylan)

    OverviewThis is a summary of the European public assessment report (EPAR) for Entecavir Viatris (previously Entecavir Mylan). It explains how the Agency assessed...

    Atectura Breezhaler | European Medicines Agency (EMA)

    OverviewAtectura Breezhaler is a medicine that is used to keep the airways open in adults and children aged 12 years and older whose...

    Bemrist Breezhaler | European Medicines Agency (EMA)

    OverviewBemrist Breezhaler is a medicine that is used to keep the airways open in adults and children aged 12 years and older whose...

    Recarbrio | European Medicines Agency (EMA)

    OverviewRecarbrio is an antibiotic for treating adults with the following infections:lung infections caught in hospital (hospital-acquired pneumonia), including ventilator-associated pneumonia (pneumonia caught while...

    Supemtek Tetra (previously Supemtek) | European Medicines Agency (EMA)

    OverviewSupemtek Tetra is a vaccine used to protect adults against influenza (flu).Influenza is mainly caused by two kinds of influenza virus, known as...

    Truqap | European Medicines Agency (EMA)

    OverviewTruqap is a cancer medicine used in adults to treat breast cancer that is locally advanced (has spread nearby) or metastatic (has spread...

    Brinavess | European Medicines Agency (EMA)

    OverviewBrinavess is a medicine used to rapidly restore normal heart rhythm in adult patients who have recently started having atrial fibrillation. Atrial fibrillation...

    Kimmtrak | European Medicines Agency (EMA)

    OverviewKimmtrak is a medicine used to treat adults with a type of eye cancer called ‘uveal melanoma’. It is used when the uveal...

    BeneFIX | European Medicines Agency (EMA)

    OverviewThis is a summary of the European Public Assessment Report (EPAR) for BeneFIX. It explains how the Committee for Medicinal Products for Human...

    Ibrance | European Medicines Agency (EMA)

    OverviewIbrance is a cancer medicine used to treat breast cancer when the cancer is locally advanced (has spread nearby) or metastatic (has spread...

    Holoclar | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Holoclar. It explains how the Agency assessed the medicine to recommend...

    Pedea | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

    Pregabalin Viatris (previously Pregabalin Mylan)

    OverviewPregabalin Viatris is a medicine used to treat adults with the following conditions:• neuropathic pain (pain due to nerve damage), including peripheral neuropathic...

    Tygacil | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Tygacil. It explains how the Committee for Medicinal Products for Human...